Search results for "Fen"

showing 10 items of 3710 documents

Results from a phase III trial (GRID) evaluating regorafenib (REG) in metastatic gastrointestinal stromal tumour (GIST): Subgroup analysis of outcome…

2013

10551 Background: REG, an oral receptor kinase inhibitor with activity against KIT, PDGFR, VEGFR, FGFRs, and other oncologic targets, demonstrated significant improvement in progression-free survival (PFS) over placebo (PL) in a phase III study (GRID) of patients (pts) with advanced GIST following failure of at least imatinib (IM) and sunitinib (SU). To understand the impact of pts’ baseline characteristics on outcome, we performed an exploratory analysis of REG effects across pt subgroups based on sex, age, and mitotic index of primary GIST tissue, as well as duration and number of lines of previous therapies. Methods: Adult pts with metastatic GIST (n=199) progressing after at least IM a…

Cancer ResearchStromal cellbiologyGiSTKinasebusiness.industryVEGF receptorsSubgroup analysischemistry.chemical_compoundOncologychemistryRegorafenibbiology.proteinCancer researchMedicineReceptorbusinessPlatelet-derived growth factor receptor
researchProduct

Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription

2003

AbstractRecent efforts to develop pharmacologic agents that restore function to mutant forms of p53 hold significant promise in cancer therapy. Here, we examine the effects of such pharmacologic activation of p53 function using a small molecule, PRIMA-1, and a model system employing a p53 protein fused to a mutant steroid binding domain of the murine estrogen receptor (p53ERtam) that renders it responsive only in the presence of 4-hydroxytamoxifen. In either case, p53 activation triggered apoptosis that was not inhibited by the presence of macromolecular synthesis inhibitors. This p53-induced, transcription-independent apoptosis is Bax dependent, proceeds in the absence of a nucleus, and in…

Cancer ResearchTranscription GeneticRecombinant Fusion ProteinsMutantEstrogen receptorApoptosis03 medical and health sciencesMice0302 clinical medicineBcl-2-associated X proteinProto-Oncogene ProteinsTumor Cells CulturedAnimalsHumansCloning MolecularReceptorCells Cultured030304 developmental biologybcl-2-Associated X ProteinCell NucleusProtein Synthesis Inhibitors0303 health sciencesAza CompoundsbiologyCytochrome cCytochromes cCell BiologyFibroblastsBridged Bicyclo Compounds Heterocyclic3. Good healthCell biologyTransport proteinMitochondriaProtein TransportTamoxifenProto-Oncogene Proteins c-bcl-2Receptors EstrogenOncologyApoptosis030220 oncology & carcinogenesisMutationbiology.proteinTumor Suppressor Protein p53Binding domainCancer Cell
researchProduct

Apoptosis: focus on sea urchin development

2009

It has been proposed that the apoptosis is an essential requirement for the evolution of all animals, in fact the apoptotic program is highly conserved from nematodes to mammals. Throughout development, apoptosis is employed by multicellular organisms to eliminate damaged or unnecessary cells. Here, we will discuss both developmental programmed cell death (PCD) under normal conditions and stress induced apoptosis, in sea urchin embryos. Sea urchin represent an excellent model system for studying embryogenesis and cellular processes involved in metamorphosis. PCD plays an essential role in sculpting and remodelling the embryos and larvae undergoing metamorphosis. Moreover, this marine organi…

Cancer Researchanimal structuresmedia_common.quotation_subjectClinical BiochemistryDefence mechanismsPharmaceutical ScienceApoptosisEmbryos PCD Stress CaspasesApoptosis evolution EchinodermsEvolution Molecularbiology.animalAnimalsSettore BIO/06 - Anatomia Comparata E CitologiaMetamorphosisSea urchinCaspasemedia_commonPharmacologybiologyEcologyBiochemistry (medical)EmbryogenesisEmbryoCell BiologyCell biologyMulticellular organismApoptosisSea Urchinsembryonic structuresbiology.proteinApoptosis
researchProduct

Does tamoxifen change oestrogen and progesterone receptor expression in the endometrium and breast?

2000

We studied the expression of oestrogen and progesterone receptors (ER, PR) in postmenopausal women receiving tamoxifen for breast cancer. In addition the literature addressing the question of ER and PR expression in breast tissue during treatment with tamoxifen was reviewed. We demonstrated consistent expression of ER and PR in endometria from patients receiving tamoxifen, with a trend towards a higher proportion of receptor positive specimens during tamoxifen. In breast cancer tissue, the ER content seemed to be reduced following tamoxifen treatment. After short time exposure to tamoxifen, the PR appeared to be increased, longer treatment caused the PR to go down to pretreatment levels or …

Cancer Researchmedicine.medical_specialtyAntineoplastic Agents Hormonalmedicine.drug_classMammary glandBreast NeoplasmsEndometriumEndometriumBreast cancerInternal medicineProgesterone receptormedicineHumansBreastskin and connective tissue diseasesbusiness.industryAntiestrogenmedicine.diseaseEndometrial NeoplasmsTamoxifenmedicine.anatomical_structureEndocrinologyOncologyReceptors EstrogenEstrogenImmunohistochemistryFemalebusinessReceptors Progesteronehormones hormone substitutes and hormone antagonistsTamoxifenmedicine.drugEuropean journal of cancer (Oxford, England : 1990)
researchProduct

3H-estradiol and3H-R5020 binding in cytosols of normal and neoplastic human ovarian tissue

1983

High-affinity cytoplasmic estrogen and progesterone receptors in normal and abnormal ovarian tissues were studied. Estradiol receptor was detectable in 65% and progesterone receptor in 36% of the malignant tumors; 39% of all malignant ovarian tissues were estradiol- as well as progesterone-receptor-positive. Tumors were said to be receptor-positive when the receptors bound greater than 5 fM steroid/mg cytosol protein. No correlations were found between receptor status and histopathological diagnosis. In normal ovarian tissues collected at various phases of the menstrual cycle no changes in [3H]-estradiol and [3H]-R5020 binding could be detected. Analysis of the receptor concentration for bo…

Cancer Researchmedicine.medical_specialtyReceptor StatusNorpregnadienesmedicine.drug_classmedia_common.quotation_subjectOvaryReceptors EstradiolBiologyTritiumPromegestoneCytosolOvarian carcinomaInternal medicineProgesterone receptormedicineHumansEstrogen Receptor StatusMenstrual cyclemedia_commonOvarian NeoplasmsTranscortinEstradiolOvaryEndocrinologymedicine.anatomical_structureReceptors EstrogenOncologyEstrogenFemaleReceptors Progesteronehormones hormone substitutes and hormone antagonistsTamoxifenmedicine.drugInternational Journal of Cancer
researchProduct

Droloxifene-Induced Spikes of Tumor Markers Predict Benefit of Therapy

1991

In the clinical monitoring of cancer, tumor marker proteins may reflect the status of the disease. In cases with radio- and chemotherapy, spikes of tumor markers were found shortly after starting the therapy. These spikes were interpreted as a sign of tumor lysis. Recently during therapy of breast cancer with the new antiestrogen droloxifene, spikes of CA 125 and CA 15-3 were also found in about one-third of patients responding to therapy. The peaks of these initial increases were recorded between 14 and 60 days after the onset of treatment, with maximum concentrations up to 1,890% of the initial value. Marker concentrations decreased thereafter, to new baselines at or below the initial val…

Cancer Researchmedicine.medical_treatmentRadioimmunoassayAntineoplastic AgentsBreast NeoplasmsBreast cancerPredictive Value of TestsmedicineHumansAntigens Tumor-Associated CarbohydrateAgedTumor markerChemotherapybusiness.industryEstrogen AntagonistsCancerRadioimmunoassayMiddle Agedmedicine.diseaseAntiestrogenTamoxifenTreatment OutcomeOncologyPredictive value of testsCancer researchDrug EvaluationFemalebusinessTamoxifenmedicine.drugAmerican Journal of Clinical Oncology
researchProduct

Robust Antigen-Specific T Cell Activation within Injectable 3D Synthetic Nanovaccine Depots

2021

Contains fulltext : 244693.pdf (Publisher’s version ) (Open Access) Synthetic cancer vaccines may boost anticancer immune responses by co-delivering tumor antigens and adjuvants to dendritic cells (DCs). The accessibility of cancer vaccines to DCs and thereby the delivery efficiency of antigenic material greatly depends on the vaccine platform that is used. Three-dimensional scaffolds have been developed to deliver antigens and adjuvants locally in an immunostimulatory environment to DCs to enable sustained availability. However, current systems have little control over the release profiles of the cargo that is incorporated and are often characterized by an initial high-burst release. Here,…

Cancer development and immune defence Radboud Institute for Molecular Life Sciences [Radboudumc 2]T-LymphocytesT cellBiomedical Engineering02 engineering and technologySDG 3 – Goede gezondheid en welzijnantigen-specific T cellsCancer VaccinesArticleBiomaterials03 medical and health sciencesbiomaterial-based scaffoldsImmune systemAntigenSDG 3 - Good Health and Well-beingAntigen specificControlled deliverymedicineLactic Aciddendritic cells030304 developmental biology0303 health sciencesChemistryBiomaterial021001 nanoscience & nanotechnologyCell biologymedicine.anatomical_structureDelivery efficiencynanoparticles0210 nano-technologycancer vaccinationNanomedicine Radboud Institute for Molecular Life Sciences [Radboudumc 19]Polyglycolic Acid
researchProduct

Short-term response of the Ca cycle of a montane forest in Ecuador to low experimental CaCl2 additions

2013

The tropical montane forests of the E Andean cordillera in Ecuador receive episodic Sahara-dust inputs particularly increasing Ca deposition. We added CaCl2 to isolate the effect of Ca deposition by Sahara dust to tropical montane forest from the simultaneously occurring pH effect. We examined components of the Ca cycle at four control plots and four plots with added Ca (2 x 5kg ha(-1) Ca annually as CaCl2) in a random arrangement. Between August 2007 and December 2009 (four applications of Ca), we determined Ca concentrations and fluxes in litter leachate, mineral soil solution (0.15 and 0.30 m depths), throughfall, and fine litterfall and Al concentrations and speciation in soil solutions…

Canopy010504 meteorology & atmospheric sciencesSoil SciencePlant ScienceCalcium cycleAl ratio [Molar Ca]01 natural sciencesDissolved organic carbonBotanyGraffenrieda emarginata TrianaOrganic matter0105 earth and related environmental scienceschemistry.chemical_classificationAl speciationBiomass (ecology)Stem diameter growthTropical montane forest04 agricultural and veterinary sciences15. Life on landPlant litterThroughfallchemistryEnvironmental chemistry040103 agronomy & agricultureLitter0401 agriculture forestry and fisheriesDeposition (chemistry)
researchProduct

Monitoring the whiting phenomenon in Lake La Cruz (Cuenca, Spain)

2020

[EN] In the present study, a five-year follow-up was performed by remote sensing of the calcium carbonate precipitation in La Gitana karstic lake also known as La Cruz (located on the province of Cuenca, Spain). The important role that calcium carbonate precipitation plays in the ecology of the lake is well known for its influence on the vertical migrations of phytoplankton, the concentration of bioavailable phosphorus and, therefore, the eutrophication and quality of the waters. Whiting take place between the months of July and August, and it can be studied at this time through its optical properties, with the main objective of offering updated data on a phenomenon traditionally studied an…

Carbonato cálcicoTeledetecciónKarstPrecipitationRemote sensingWhitingCalcium carbonateFenómeno blancoPrecipitación
researchProduct

Response and Recovery of Brain Acetylcholinesterase Activity in the European Eel,Anguilla anguilla,Exposed to Fenitrothion

1998

European eel (Anguilla anguilla) were exposed to sublethal fenitrothion concentrations in a continuous flow-through system for 4 days. Brain acetylcholinesterase (AChE) activity was evaluated after 2, 8, 12, 24, 32, 48, 56, 72, and 96 h pesticide exposure. Results indicated that AChE activity in eel brains decreased as the concentration of fenitrothion increased. The pesticide induced significant inhibitory effects on the AChE activity ofA. anguilla,ranging from >40% inhibition at a sublethal concentration of 0.02 ppm to >60% inhibition at a sublethal concentration of 0.04 ppm. Eel were exposed to both fenitrothion concentrations for 96 h and then allowed a period of recovery in pesticide-f…

Carboxylic Ester HydrolasesInsecticidesmedicine.medical_specialtyAchéHealth Toxicology and MutagenesisBiological effectFenitrothionchemistry.chemical_compoundInternal medicinemedicineAnimalsDose-Response Relationship DrugPublic Health Environmental and Occupational HealthBrainFenitrothionGeneral MedicinePesticideAnguillaPollutionAcetylcholinesteraselanguage.human_languageEuropeEndocrinologychemistryToxicityAcetylcholinesteraselanguageCholinesterase InhibitorsWater Pollutants ChemicalRecovery phaseEcotoxicology and Environmental Safety
researchProduct